BC Cancer researchers leading the development of immunotherapies targeting the surface protein IL1RAP for the treatment of Ewing sarcoma
Dr. Poul Sorensen, Distinguished Scientist at BC Cancer, in collaboration with Dr. Kevin Hay, Clinician-Ccientist at BC Cancer, and Dr. Wei Li, Assistant Professor at the University of Pittsburgh, received support from the Rutledge Cancer Foundation to develop and optimize novel immunotherapies targeting the surface protein IL1RAP for the treatment of Ewing sarcoma.